- In February 2025, the U.S. Department of Agriculture granted conditional clearance to Zoetis for its bird flu vaccine for poultry. This approval comes in response to nearly 70 human infections and one death since April 2024, emphasizing the need for effective preventive measures in poultry populations
- In December 2024, the USDA announced a new strategy to test cow's milk for the H5N1 bird flu strain. This testing aims to monitor and control the spread of the disease, which has affected over 110 million poultry and some wild birds, and has extended to U.S. cattle herds and humans
- In October 2024, Quest Diagnostics announced the launch of a new test for the H5N1 bird flu, following contracts from the U.S. Centers for Disease Control and Prevention (CDC). This test aims to enhance the detection and management of avian influenza outbreaks, which have led to the culling of over 100 million birds in the U.S. since 2022
- In June 2022, Zoetis Inc. expanded its animal health and pet care portfolio by acquiring Basepaws, a company specializing in genetic testing for pets. This acquisition strengthens Zoetis' position in the veterinary diagnostics market by enhancing its capabilities in precision and personalized medicine for companion animals.
- In June 2022, IDEXX Laboratories introduced a new, integrated poultry diagnostics platform that combines advanced testing capabilities with a dedicated software solution. This platform is designed to help poultry producers monitor flock health more effectively and manage disease outbreaks through improved diagnostic accuracy and real-time insights
